Buerger disease, also known as thromboangiitis obliterans, is a rare inflammatory disorder of the blood vessels. It is most commonly seen among young men who smoke, but it can also affect women and non-smokers. The cause of Buerger disease is unknown, but it is thought to be an autoimmune disorder. This means that the body's immune system attacks its own blood vessels, causing them to become inflamed and blocked. The disease typically affects the arteries and veins in the hands and feet, leading to pain, swelling, and ulceration. Early detection and treatment are essential for preventing further damage and improving quality of life.
Buerger disease is an inflammatory disorder of the blood vessels that primarily affects the arteries and veins in the hands and feet. It is an autoimmune disorder, meaning that the body's immune system mistakes its own blood vessels as foreign and attacks them. This leads to inflammation and narrowing of the blood vessels, which can cause pain, swelling, and ulceration of the affected areas. Buerger disease is most common in young men between the ages of 20 and 40 who smoke, but it can also affect women and non-smokers.
The exact cause of Buerger disease is unknown, but it is believed to be related to smoking. Smoking increases the risk of developing Buerger disease, and most people with the condition are current or former smokers. Other risk factors include family history, certain autoimmune disorders, and exposure to certain toxins.
The most common symptom of Buerger disease is pain in the hands and feet. This pain is usually worse at night and can be accompanied by swelling, numbness, tingling, and discoloration of the affected area. In advanced cases, ulceration and gangrene may occur.
Buerger disease can be difficult to diagnose because the symptoms are similar to other conditions. To diagnose Buerger disease, a doctor will typically take a medical history and perform a physical exam. The doctor may also order imaging tests such as X-rays, CT scans, and MRIs to look for signs of inflammation and narrowing of the blood vessels. Blood tests may also be done to look for signs of infection or autoimmune disorders.
The primary treatment for Buerger disease is to stop smoking. This is essential for slowing the progression of the disease and reducing the risk of complications. Other treatments include medications to reduce inflammation, relieve pain, and prevent blood clots. In severe cases, surgery may be needed to remove damaged blood vessels or to bypass them with healthy vessels.
The best way to prevent Buerger disease is to quit smoking. If you are a smoker, it is important to quit as soon as possible to reduce your risk of developing the disease. If you are a non-smoker, it is important to avoid secondhand smoke and other toxins that may increase your risk of developing the disease.
Buerger disease is a rare inflammatory disorder of the blood vessels that can cause pain, swelling, and ulceration of the hands and feet. The cause of the disease is unknown, but it is thought to be an autoimmune disorder. Early detection and treatment are essential for preventing further damage and improving quality of life. The best way to prevent the disease is to quit smoking, and if you are a smoker, it is important to quit as soon as possible.
1.
Q&A: When will individuals be able to receive customized cancer vaccines?
2.
Canadian Group Calls for Earlier Colorectal Cancer Screening
3.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
4.
Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.
5.
Talquetamab Combos Show Survival Benefit in r/r Myeloma
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Personalized Tumor Ecological Landscapes in Oncology
5.
Unmasking the Subtle Symptoms of Colon Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation